Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response.
about
Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell linesEffects of Ginkgo biloba on chemically-induced mammary tumors in rats receiving tamoxifenCohesin is required for activation of MYC by estradiol.Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancerEnhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers.BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinibSynergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells.Recent advances in SCF ubiquitin ligase complex: Clinical implicationsEnhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer.Runx Genes in Breast Cancer and the Mammary Lineage.Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells.Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer.The critical role of histone lysine demethylase KDM2B in cancer
P2860
Q28259553-D92EB68E-5E02-4C1C-B7C0-63BCB4553E40Q28703563-B13916F6-9D8A-438D-99B6-D3B07ABE673BQ34474156-E57ABF13-8947-4B1C-9DAE-729F4CAC727AQ36067934-59EA8CF8-C18A-4762-9C71-44D60FEC3775Q36245645-2254D826-128D-475A-9C36-DA29A0AF39A8Q36299102-080CE8C2-7EE4-4DC2-BBD2-F5C99C252902Q36996317-916D3B9E-E222-478B-B044-BF6825A7703AQ38828721-CDA5B29B-AAF6-4B4E-AFA6-E1078F417FB3Q38920711-CB459EC6-1F28-48C0-B7A4-8EE25DCD9EA9Q39181420-F9EB11FA-19B2-47C6-83C7-8A420384A69FQ39555908-6759FAAE-A31D-4A27-B5B5-43E230F421CEQ40522259-C51C81EB-2587-4780-9B56-7C34AEB8A047Q55265188-7E305884-6BEA-4B76-AA9B-261D03CE916CQ58776048-CD1059AF-7540-4628-8A82-8CA535298464
P2860
Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Selective recruitment of breas ...... nd tamoxifen therapy response.
@ast
Selective recruitment of breas ...... nd tamoxifen therapy response.
@en
type
label
Selective recruitment of breas ...... nd tamoxifen therapy response.
@ast
Selective recruitment of breas ...... nd tamoxifen therapy response.
@en
prefLabel
Selective recruitment of breas ...... nd tamoxifen therapy response.
@ast
Selective recruitment of breas ...... nd tamoxifen therapy response.
@en
P2093
P356
P1476
Selective recruitment of breas ...... nd tamoxifen therapy response.
@en
P2093
Anieta M Sieuwerts
Danielle Meijer
John A Foekens
Lambert C J Dorssers
Marion E Meijer-van Gelder
Roya Sarwari
Stefan Sleijfer
Thecla L A van Agthoven
Ton van Agthoven
P304
P356
10.1677/ERC-09-0062
P577
2010-02-18T00:00:00Z